Feeds:
Posts
Comments

Archive for the ‘Blogfinger Medical Reports’ Category

Internet cartoon.

 

Medical practices spend an average of two business days a week per physician to comply with health plans’ inefficient and overused prior-authorization (PA) protocols. One-third of practices employ staffers who spend every second of their working hours on PA requests and follow-ups. But some relief appears to be coming, as the AMA and joins forces with some payers to fix this broken process. Read more at AMA Wire®.

This quote is from the AMA Morning Rounds:  “Physicians have, for many years, expected to face prior-authorization hurdles for a few new or unusually expensive medications or tests. But, more recently, insurers have rapidly added PA requirements to more and more treatments,”

Blogfinger Medical Commentary:  Paul Goldfinger, MD, FACC

Some of you may have experienced rejection of a particular prescription drug by your drug plan. But such rejections typically get reversed by enlisting your doctor’s help, and that would require his time and that of his staff to deal with the insurance company.  The process is called “prior-authorization.”

In the article above, from the AMA, they discuss the problem from the perspective of the physician, but I have experienced it myself, from the perspective of the patient.

And, without a doubt, the episodes of prior authorization have increased noticeably for patients, but, as discussed above, also for the prescribing physician and his staff.

And now we see insurance companies questioning even cheap generics or chronically used stable medications,  and the issue isn’t always the drug choice itself.

For example, I recently ran into this situation related to my use of a high blood pressure medication that is perhaps the number one or number two choice prescribed by doctors for their patients with hypertension.

In my case, I was doing very nicely with two 5 mg. tablets each morning of that drug   (10 mg per day)—lisinopril, an ACE inhibitor. However recently my doctor wanted me to increase the dose from two tabs each day to two tabs twice per day  (20 mg per day), ie 4 tabs per day instead of 2.

So I would need 360 tabs per 90 days instead of 180 tabs per 90 days—-a perfectly reasonable dose change.    I was notified that they would not send me my medication because it required the prior authorization process.     Meanwhile I was running out of medications while the plan would try to get my doctor to respond.  And the drug plan was contacting me by mail and phone messages to raise the PA alarm.

I couldn’t understand why this innocuous dose change was a problem—it’s a cheap drug with a zero  copay.  I was baffled, so I called the company, but the customer service representative couldn’t figure out why prior authorization was being applied to my prescription.  She advised me to wait for the process to play out.  This was unacceptable.

I  thought about the problem, and it dawned on me that maybe the number of pills was the issue, and not the medication itself.

Maybe the problem was the 360 tablet requirement, every 90 days.   Being a physician I was able to call and  speak to a pharmacist at the mail order plan. He verified that the number of pills was the problem, not the dose.

So I asked if we could change the tablet size from 5 mg. to 10 mg, making the daily dose two tabs each day.  He said “fine” and a few days later I received 180 of the 10 mg tabs.

But the warning letters and phone messages continued.  Finally I called the “prior authorization” department and told her that I fixed the problem myself. And she said, “Oh, when you get the letters and phone calls just ignore them until the matter is fully resolved.”

The best resolution available for most patients is to make sure that your doctor’s office staff has done their job with the paper work. It might  be easier to resolve if you buy your meds from a local pharmacy.  If you have a mail order pharmacy, as I do, and you are running out of pills, one of the local pharmacies will help you get a temporary supply, assuming that the left hand and the right hand at your drug company can resolve the problem.

 

 

 

Read Full Post »

 

FROM THE AMA:    STAT reports the flu season “is off to an early start this year” and could “peak over the holidays,” a new CDC indicates. The piece says the “wildly unpredictable” flu viruses leave experts uncertain of precisely how extensive the season will be, but the CDC’s weekly flu reports offer updated predictions and data, with the most recent report showing “that Louisiana and Oklahoma already have widespread flu activity and some nearby states are heating up too.” According to CDC influenza epidemiologist Lynnette Brammer, who leads flu reporting, “If it continues to go up like it has the last couple of weeks, yeah, we could have a fair amount of activity right at Christmas.”

 

BLOGFINGER MEDICAL REPORT:  By Paul Goldfinger, MD, FACC

From the Nov.  29, 2017  NEW ENGLAND JOURNAL OF MEDICINE:     “Seasonal influenza epidemics cause 3 million to 5 million severe cases and 300,000 to 500,000 deaths globally each year, according to the World Health Organization (WHO). The United States alone sees 140,000 to 710,000 influenza-related hospitalizations and 12,000 to 56,000 deaths each year, with the highest burden of disease affecting the very young, the very old, and people with coexisting medical conditions.  (BF bold print)

“However imperfect, though, current influenza vaccines remain a valuable public health tool, and it is always better to get vaccinated than not to get vaccinated. In this regard, the CDC estimates that influenza vaccination averted 40,000 deaths in the United States between the 2005–2006 and 2013–2014 seasons.2 Yet we can do better.”

It is difficult and unpredictable to get the virus profile to be accurate, because the profiling is done early in the year, and virus mutations can appear, leaving your flu shot to have a reduced efficacy.  Usually flu shots are 40% to 60% effective, but this year, according to the New England Journal of Medicine,  “The preliminary estimate of vaccine effectiveness against influenza A (H3N2) was only 10%.”  They are referring to the Southern Hemisphere  experience earlier this year in Australia.  H3N2 is the main offender so far, although there may be others emerging now.  The transmission of the influenza virus has been accelerating sharply in the US at this time.

So, if you haven’t yet had a flu shot, rush out and get one.  Most drug stores offer it.  If you are  a member of a high risk group, such older folks  (over age 65) or those with chronic illnesses, try to avoid exposure in places with many people in close contact.  And stay away from anyone who has a “cold” or, especially, has flu-like symptoms including fever, cough, chills, muscle aches, congestion, runny nose, headaches, and marked fatigue.

If you have such symptoms, your doctor may prescribe an antiviral medication, such as Tamiflu,  if you call early in the course of your illness.

And don’t forget frequent hand washing.

 

 

Read Full Post »

 

A nice array of local produce including blackberries, blueberries, broccoli,mushrooms, and radishes. Ocean Grove display. Blogfinger photo © 7/15/17  Click  book cover to enlarge the text.

 

By Eileen and Paul Goldfinger at  @Blogfinger.net.

Most major prevention trials have concluded that fresh fruits and vegetables will help the process due to their nutritional content of  fiber and micronutrients including vitamins, minerals and antioxidants.  This dietary approach is one of the major reasons why the Mediterranean Diet has been found to be so beneficial.

There is a reason why New Jersey is called the Garden State.  Local farms are turning out a great crop for 2017 including big, beautiful beefsteak tomatoes and a record breaking peach crop.

This is the first generation in America where we can look forward to fresh produce all year round, instead of only in season, thanks to advances in packaging and shipping.  And that includes fresh seafood.

So take advantage of using these healthful Garden State ingredients over the next couple of months.  (Hint: Point Pleasant scallops–Here is a link to Eileen’s Pt. Pleasant scallops with tomato and scallion sauce)

Pt. Pleasant scallop recipe by Eileen

SHYMAN MOSES:

Read Full Post »

 

images

By Paul Goldfinger, MD, FACC

As you may know,  blood pressure measurement consists of a top number (systolic) and a bottom number (diastolic.) Both numbers are important, but recent research trials and guidelines have been focusing on the systolic end points. The exact way to express a BP reading is 120/80 mm Hg. But for this article we will just use the number–e.g. 120/80.

Blood pressures are usually taken in the sitting position.  Some doctors ask their patients to sit for 5 minutes before taking a measurement. This will result in a number that is often about 10 points lower than an immediate office reading and may be different than readings obtained at home.

I recommend that all patients with hypertension (“high blood pressure”)  buy a device and keep track of readings at  home.  I suggest an initial reading and then another after 5 minutes.   Keep a written record for your doctor with the measurements, date, time and circumstances  (eg “just had an argument with my spouse”)   Remember that blood pressure readings do vary, so show your physician all your readings when you go for an office visit.

Experts have been disagreeing lately regarding  the “target” systolic  (top) numbers that physicians should aim for when treating older patients  (over age 60) for hypertension  (high blood pressure.)

No one disagrees that treatment should begin for readings over 170, but most physicians will begin therapy for readings averaging over 150/90. Studies show benefits of treatment even for those over age 80.    Doctors will legitimately differ in deciding when to start therapy, depending on the circumstances.   The current treatment  guideline controversies surround the question of how low to go.

The basic concept is that BP control will prevent stroke and cardiac events as well as reduce cardiac mortality rates.  In older individuals, there is a special concern regarding lowering the systolic number too much.

If the BP is caused to be too low, quality of life issues may take center stage including important problems such as fainting, dizziness, cognitive impairment, depression, hip fractures, impotence, and  fatigue.   Sometimes patients will stop their meds due to such reactions. Tell your physician if you suspect side effects.

There are a variety of  drugs that doctors use to treat hypertension and they are often utilized in combination.  If you doctor wants to use beta blockers, keep in mind that this class of drugs may not be as effective for prevention as others and may be associated with significant side effects.*

One recent discovery is that statin drugs, added to anti-hypertensive drug therapy, will improve the prognosis regardless of LDL (“bad”) cholesterol levels.

The JNC 8 (Joint National Committee) guidelines came in 2013,  after not revising the recommendations for over 10 years.   They decided to lighten up on their target systolic reading concluding that up to 150  was OK for “seniors” instead of the prior goal of 140.

But some experts would prefer to see the pressure lowered to below 140,  and even to 130 if tolerated by the patient, especially if the patient is at higher risk, such as diabetics and those with prior stroke, TIA, known heart disease or significant risk factors.

Another recent trial called Sprint advocated a target below 120 for patients 75 and older. The study found that patients with a target of 120 did better than those with 140, but that study was criticized on procedural grounds, and that goal could be risky in older patients who run a significant risk of side effects with such low readings.  Even 130  may be associated with problems. The doctor has to be very careful when aiming for those aggressive targets.

So what is the physician to do given all these disagreements?    The answer is to be knowledgeable regarding research  trials and  official guidelines, but to decide each case individually.

Dr Franz Messerli , a BP specialist and Clinical Professor of Medicine at Columbia U. School of Medicine is quoted on Medscape Cardiology  2/28/17.:    “After JNC 7, it took 11 years to get one more set of guidelines. Now we have six or seven, and they all tell a different story. It has become very confusing to the practicing clinician.

The patient in front of you never quite conforms to the patient in the trial or to the patients from whom the evidence was derived for the latest guidelines. Despite all the guidelines, you still have to be a doctor, and you have to individualize therapy and continue to learn.

Dr. Messerli concluded by saying, “Most physicians know that guidelines are more for lawyers than for doctors.”

*Prof. Messerli:  “Despite lowering blood pressure, there is no— and I repeat, no—evidence that beta-blockers reduce heart attack, stroke, or death in hypertensive patients ≥ 60 years. Ironclad evidence has been put forward that beta-blockers are not acceptable antihypertensive drugs in this age group.”  

Here is an important link from our series on treating hypertension. It is from 2013.  You can read our other posts in that series by typing “hypertension” into our search bar (above).

https://blogfinger.net/2013/12/23/confessions-of-a-high-blood-pressure-doctor-part-ii-controversy-emerges-regarding-the-jnc8-practice-guidelines-for-hypertension/

 

 

Read Full Post »

unknown-1

newest-ama

noexcusesbannersmall

3-d portrayal of the H3N2 influenza A virus.    CDC

3-d portrayal of the H3N2 influenza A virus. CDC

The NBC Nightly News (1/6, )  briefly reported that the Centers for Disease Control and Prevention “says this [flu] season is worse than last,” with “more than 10,000 cases reported nationwide.” Physicians are saying, however, that the “flu shot is a good match for this year’s dominant strain and it’s not too late to get one.”
USA Today (1/6) reported that federal epidemiologist Lynnette Brammer said “while it’s too early to tell if the annual flu vaccine is effective, it closely matches the strains of flu commonly in circulation, which suggests it will be effective.”
Meanwhile, the Washington Post (1/7) said that according to the recent CDC report, “only 2 out of 5 Americans have received the shot so far this flu season.”

NJ.com :    During the closing week of 2016, Monmouth County had the most number of positive flu tests, followed by Essex, Bergen, and Ocean counties.

Blogfinger medical commentary.  Paul Goldfinger, MD:

Monmouth County has been among the most seriously affected in New Jersey with the flu.  The virus which is responsible, the H2N3 strain of Influenza A ,is the same as the strain which caused many people in 2014 to get so ill.  Now the flu attacks tend to be more severe and more sustained.  The peak season is December through February, and there is still time to get the vaccine.  The most severely affected tend to be the very young and the very old.

The demand for the vaccine is quite high now, and everyone, all ages,  should get it unless there is some specific reason not to (such as egg allergies.)

 

Read Full Post »

Paul Goldfinger, MD. Mt. Sinai intern c. 1967.

Paul Goldfinger, MD. Mt. Sinai intern c. 1967.  (photo originally posted on BF a few years ago.)

I was a “straight medical” intern at Mt. Sinai Hospital, one of 12.  Of course there were other flavors such as surgery and pediatrics.  The hospital is located at the border between the sophisticated upper east side and “Spanish Harlem” to the north.  I lived with Eileen in hospital housing and walked to work down some poor streets, sometimes at night, but everyone was friendly—it was actually comforting to feel the respect coming my way just because of those “whites.”   Actually, New York City turned out to be a collection of neighborhoods.

On the way I would turn north onto Madison Avenue, passing a newsstand where, one day, I saw the headline announcing the first heart transplant.  One night, at around 2 am, I delivered a baby in the back of a taxi cab .

This hospital was an international referral center. I was so proud to be there.  One of my first patients was a man from Peru with a rare and serious disorder.  He gave me a tiny sterling silver spoon which we still treasure.  Many of the patients on the teaching service had diseases which I had never seen before.   They gave us those “whites” and they even did our laundry.  The other house officers came from med schools from  all over America.  The attending physicians were brilliant, and four major medical journals were published there.  The leading cardiology textbook in the world was by my boss Charles Friedberg, MD.

There are stories to share.   Here is a link to the one previously posted about the baby on Madison Avenue

https://blogfinger.net/2011/10/02/medical-a-special-delivery-on-madison-avenue/

DEAR THEODOSIA.  A baby is born.   From the Broadway hit:  Hamilton

 

Read Full Post »

 

Where's the pink? Public housing in Neptune Township, NJ. Blogfinger photo. May, 2016.

Where’s the pink? Public housing in Neptune Township, NJ. Blogfinger photo. May, 2016.

Blogfinger Medical Commentary.   Paul Goldfinger, MD, FACC

Many of you understand the meaning of the pink ribbons. Those who do probably don’t need to be reminded to get mammograms, but, for those of you who don’t know what the pink ribbons mean, they are supposed to increase breast cancer awareness—especially  the need to keep up with mammogram screenings.   I won’t attempt to speak for Meridian, the mammogram-industrial complex that sponsors the pink campagn, but I can share a few facts about breast cancer,  since it is May.

About 65% of all women over age 40 do  keep up with mammogram screening, but there are many who do not   There are a variety of reasons for that, and the Susan G. Komen website can tell you more on that subject (click link below)

Komen web site

It used to be that black women had a lower percent of mammogram screenings than whites, but that difference no longer exists. But it is still true that black women have higher mortality rates from breast cancer than whites.

From the Susan G. Komen web site. 2016.

From the Susan G. Komen web site. 2016.

This quote is from the  Komen web site:     “Overall, breast cancer incidence (rate of new cases) is slightly lower among African-American women than among white women.  However, breast cancer mortality (death) is higher in African-American women.

“For example, in 2013 (most recent data available), breast cancer mortality was 39 percent higher in African-American women than in white women.”

In view of that, you would think that the breast cancer pink program at Meridian would reach out to black neighborhoods with their pink ribbons and an all-out publicized education effort.

But if you drive by the public housing “projects,” as I did,  in Asbury Park and Neptune, there are no pink ribbons to be seen. This is not the first time I have pointed that out.

Meridian should be engaged in an outreach program for African-American communities in Monmouth County.  So how about some  pink ribbons and pamphlets over there?  Actually they should send a group of women, armed with facts and pamphlets, to knock on doors and set up booths in those places.  Better awareness in African-American populations could likely improve those mortality stats.

The statistics regarding the latest controversies about mammogram screenings can be found on BF by typing “breast cancer” or “mammograms”  into our search box on the top right of this page.

Paul Goldfinger, MD

CACHAO:

 

Read Full Post »

newest ama
images

The CBS Evening News (5/3) reported that research indicates that “medical errors are now the third largest cause of death behind heart disease and cancer.”

USA Today (5/3, O’Donnell) reports that the study authors “wrote that strategies to reduce death from medical care should include making errors ‘more visible’ when they occur, having remedies available to ‘rescue patients,’ and making errors less frequent by following principles that take ‘human limitations’ into account.”

www.usatoday.com/story/news/politics/2016/05/03/second-study-says-medical-errors-third-leading-cause-death-us/83874022/

According to the Washington Post (5/3, Cha), “In 1999, an Institute of Medicine report calling preventable medical errors an ‘epidemic’ shocked the medical establishment and led to significant debate about what could be done.” The institute, “based on one study, estimated deaths because of medical errors as high as 98,000” annually. The new research, published in the British Medical Journal, “involves a more comprehensive analysis of four large studies…that took place between 2000 to 2008.”

www.washingtonpost.com/news/to-your-health/wp/2016/05/03/researchers-medical-errors-now-third-leading-cause-of-death-in-united-states/

The New York Times (5/3, Bakalar) “Well” blog reports that the researchers “estimated that an average of 251,454 deaths per year in the United States are caused by medical error.”

 

Blogfinger Medical Commentary  by Paul Goldfinger, MD, FACC:

It’s been known for about thirty years that there are nearly 100,000 deaths per year due to medical errors, with most reports coming from hospitals. Newer tabulations have been used to generate the latest number (above) of  about 250,000. The Department of Health and Human Services reported that 180,000 Medicare recipients die each year from medical errors.  Some might quarrel with the numbers, but certainly it is clear that a huge number of patients are dying due to medical errors.

The U.S.  has a national network of medical schools that tend to be of high quality, and the admissions are so competitive that only smart people get in, so I don’t think that dumb doctors are the cause of these findings.

The numbers that we are discussing tend to be  due to errors of omission or of commission, and such errors often begin with poor communication, carelessness, wrong diagnoses, poor training of personnel, and ineffective monitoring routines.  Errors may involve nursing or support personnel as well as physicians. Sometimes a sequence of mistakes results in a death, so culpability may be spread around in a particular case.

And then there are the inadequate designs of medical practices including a lack of sufficient safety nets in healthcare facilities of all kinds. In the new healthcare system, there are challenges due to huge numbers of patients, assembly line procedures to augment profits, and corporate management with no knowledge of patient care.

Since stupid doctors are not usually the problem, I have found that the main malfunctions are  wrong incentives—especially financial, inattention to detail, ethical lapses, rushing to meet deadlines, sloppiness in procedures and care, and, today, a breakdown in the time-tested details of care.  Doctors have become employees.  They used to determine the procedures that govern care in hospitals and offices, but now managers who don’t understand how medical care is supposed to work have taken charge.

The safeguards that protect patients are seriously deficient across the country. There are no comprehensive mechanisms to investigate mistakes, and there are no reliable reporting procedures to identify errors and evaluate them.  Even in malpractice suits, when evidence of mistakes are often disclosed, legal gag orders prevent the information from getting out.

When I started in practice, my background was at first-rate training institutions where I rarely saw errors.  The same was true in the large military hospital where I worked, but things were much different out in the real world of private practice where, as a consultant,  I saw mistakes on a daily basis. In US hospitals, over the years, many programs were instituted to identify errors such as establishing intensive care monitoring committees to round in the ICU/CCU to look for quality issues, and we found plenty of questionable care.

As ICU/CCU chairman of our new committee,  I recall going to the medical staff to inform them of our rounding plans. The President of the staff, an arrogant surgeon, reacted by saying, “Nobody is gaining access to my patients’ charts.”  But we won that battle and were empowered to intervene when necessary.  We also were enablers for our highly trained nurses to be able to question the orders and plans coming from the doctors.

Other procedures to prevent errors have been devised, but obviously, not enough is being done.

The surgeon from Johns Hopkins who was the lead author of the study above pointed out that our society spends fortunes on cancer and heart disease care, but very little on the third leading cause of death——medical errors.  This problem has not been widely recognized, and it is an issue around the world.  It is likely that many of the errors are preventable if only funds were available to tackle the issue.

I might add that a huge arena which has not been analyzed at all is that of the private medical office practice. Most doctors are trained in hospitals. Then they open offices where there are many quality challenges.  Some doctors have been very good at following the standards of good medicine, while other office practices are awful, dangerous places. Today, with corporate incompetents  in charge of offices, I find that it is rare for me to interact with an office practice and not find something worrisome going on.

What to do?  The first thing is for organized medicine to reclaim the traditional doctor-patient relationships and then get strict with doctors regarding their priorities  (“Always place the patient first” is a traditional primary value of the medical profession.)  And the government needs to finance innovative approaches to saving lives threatened by errors.

 

Read Full Post »

newest ama

Good Morning Dr. Paul Goldfinger. Here are today’s top stories. Tuesday, January 12, 2016

Source of this mammogram: Associated Press photo at the Washington Post.

Source of this mammogram: Associated Press photo at the Washington Post.

The CBS Evening News (1/11, )  reported that the United States Preventative Services Task Force (USPSTF) “issued new guidelines for when women and how often women should be screened for breast cancer.” CBS’ Jon Lapook added that the USPSTF “says women of average risk should make an individual choice about whether to screen between the ages of 40 and 49 and be screened every other year between 50 and 74.” Lapook added, “Some doctors worry about the message these new guidelines may be sending to younger women.”

On NBC Nightly News (1/11, ), NBC’s Anne Thompson said, “The ever-shifting guidelines for starting mammograms leaves some women feeling like they are playing a game of chance.”

The Washington Post (1/12) points out that the USPSTF’s “final recommendation is likely to be controversial because some other groups say the screening should start earlier.”

The New York Times (1/12, ) reports, “The recommendations are not immediately expected to affect insurance coverage.”

 

Blogfinger Medical Commentary by Paul Goldfinger, MD, FACC, Blogfinger Off-Shore School of Medicine based in the seaside town of Ocean Grove.

As many of you know, we have taken an interest in the subject of mammography screening to prevent deaths from breast cancer.  It is not an easy topic; it is hotly debated and laced with emotion.  You may recall my controversial opinions about painting the town pink while failing to educate the public about breast cancer.  You can do a BF search above to follow our articles about this topic.

I am not a specialist in cancer, but I am fascinated by this debate partly because of my long-term interest in evidence-based medicine. In this case, we have a clash of opinions by world renowned experts in the field, so how do doctors resolve the differences in the interest of doing right by their patients?

I am floored by the latest solution which is to let  patients decide what to do when it comes to mammography screenings. I believe that every doctor who takes care of women, especially the gynecologists, oncologists, breast surgeons and even radiologists    (who sometimes actually talk to patients) should make a clear individualized recommendation while also discussing all options with their patients.  Of course, in the end, the patient should decide.

Here are two quotes which interest me:

Washington Post:  “The debate over when to start regular screening involves only women of “average risk” who don’t have specific risk factors for breast cancer such as the BRCA1 and BRCA2 genetic mutations or a family history of the disease. They’re also not aimed at diagnostic mammography, which takes place once a woman has a symptom such as a lump. The screening recommendations are not binding on doctors, hospitals or insurers.”

This quote mentions a major advance in breast cancer screening, ie the use of genetic testing to look for high risk patients who require special attention. It also admits that decisions about mammography cannot be generalized and reduced to pinkification of our town—these decisions must be individualized, and the public needs to  be respected and taught the hard facts——not the sugar coated, color coded substitutes for real education.

NY Times: The Susan G. Komen for the Cure foundation also expressed concerns about insurance payment, and issued a statement saying that a lack of coverage would hit “high risk and underserved” women hardest, particularly black women, who are more prone than whites to aggressive types of breast cancer.

This quote interests me because, when Ocean Grove was being plastered by pink ribbons and banners, the poor black neighborhoods of Neptune and Asbury Park had nothing pink in sight. How pathetic is that!!   Shame on Meridian Health.

You would all do well to click on the Times and Post links above.

Read Full Post »

newest ama

Unknown-1

The AP (4/6) reports that the Food and Drug Administration “has approved the first pacemaker to do away with electrical wires that have long been a shortcoming of internal heart devices.” The device, called the Micra Transcatheter Pacing System, is made by Medtronic PLC and is “implanted directly into the heart’s lower-right chamber.”
The Wall Street Journal (4/7, ) reports that the device is intended for patients who have irregular heartbeats, including atrial fibrillation or bradycardia-tachycardia syndrome, according to the FDA.

New wireless pacemaker.  Medtronic photo.

New wireless pacemaker. Medtronic photo.

 

Wireless pacemaker sits in the right ventricle. No wires needed.  Internet photo. 4/16/

Wireless pacemaker sits in the right ventricle. No wires needed. Internet photo. 4/16/

 

Blogfinger Medical Commentary:   Paul Goldfinger, MD, FACC.   Blogfinger Off-shore School of Medicine, Ocean Grove, NJ

When complications occur with permanent pacemakers, often the issue is with the wires which can get infected, perforate the heart or cause clotting. Pacemakers sit in a “pocket” under the skin beneath the collar bone. That pocket is created surgically, and problems can develop such as bleeding or infection.

The generator connects to the interior of the heart with special wires, usually one or two per patient.   Years ago I ran into cases where the wire broke, became displaced,  or got infected. Sometimes a wire had to be removed, but that was a tricky procedure, and there were specialists who became known for their ability to extract wires which had become scarred into place at the tips.

Occasionally the original placement of the wire would be problematic, and I saw cases that took hours before the surgeon got the wires correctly in place. In recent years, the placement of pacemakers became the domain of cardiologists with special training, i.e. electrophysiologists.

Here is a link to our recent article about the  history of permanent pacemakers

http://blogfinger.net/2016/02/14/history-of-permanent-cardiac-pacemakers-by-a-cardiologist-whose-career-paralleled-the-evolution-of-that-technology/

The main advantages of wireless pacemakers are that surgery and wires are not needed.

Last November, a study of 725 patients was published in The New England Journal of Medicine describing a new advance: a one inch wireless pacemaker.    Such devices had already been approved in Europe for a year, but only now did the FDA approve it for use in the US.  There are two companies that make the new device: Medtronic and St. Jude—both American companies. Medtronic called its version “The Micra.”  Also Boston Scientific has one on the launching pad.

In 99% of the study cases, the new pacemaker was placed successfully, and with half the complications of the usual units. These new devices are about 1 inch long and are placed by inserting a needle into a groin vein eliminating the necessity of the surgical approach.  Prongs attach the device to the inner lining of the right ventricle. There are no wires.  This is the future of pacemakers, and this device is just the first.

However, there are some issues:

  1. Currently only 15-25% of pacemaker patients would be candidates.
  1. The battery is supposed to last for 10 years, but there are no long term trials.
  1. Techniques to remove a wireless unit are currently being developed.
  1. Anyone who needs a dual chamber pacemaker would have to await further developments
  1. These new devices are much more expensive than the current ones which work just fine most of the time.

 

 

 

 

 

 

Read Full Post »

newest ama

images

 

The Wall Street Journal (2/29 ) reports that there is increasing evidence that over-the-counter nutritional supplements may interfere with a host of prescription drugs for a variety of common conditions.

“The National Center for Complementary and Integrative Health, part of the National Institutes of Health, is funding a number of programs around the country to study potential adverse interactions that can occur between so-called natural products and prescription drugs, over-the-counter drugs such as aspirin and even small molecules in food. The risks are especially high for cancer and surgery patients and those on heart and blood-thinner medications, which have what’s known as a “narrow therapeutic range,” or small differences between beneficial and toxic doses.”   (WSJ excerpt)

Blogfinger Medical Commentary.  Paul Goldfinger, MD, FACC

This revelation is not surprising.  There is too little known about the supplements that so many people use.  The complimentary gurus often quote “research” which is of poor quality. The FDA doesn’t deal with such over-the-counter supplements, so nobody is watching for evidence of benefit or toxicity that may result from such treatments.

When doctors take a medical history they usually ask about prescription drugs, but they rarely inquire about supplements.  Before you take a supplement, especially if you are on prescription drugs, do some research online to look for possible interactions.  You can ask your doctor, but he probably knows nothing about it.

I think most supplements that make people feel better either have mild pharmacological effects or they work because of the placebo effect, a powerful force that makes phony doctors rich.  And don’t forget that supplements which are supposed to have no side effects  (“Try it, it can’t hurt”) may actually be dangerous under certain conditions as described in the  article above.

There is a very interesting book, Do You Believe in Magic–an easy read–written by a physician  (Paul A. Offitt. MD) regarding over-the-counter supplements.   Subtitle:   “The sense and nonsense of alternative medicine.”

THE HIT CREW:  (This is about a totally natural remedy which helps keep a doctor in bed at night)

 

Read Full Post »

 

images-1

 

By Paul Goldfinger, MD.  Editor @Blogfinger

I have come across two worrisome trends at the pharmacy which result in extra trips to get prescriptions and invasion of privacy by pharmacist.

The first is part of a growing trend towards deterioration of customer service in our society.  The second is about invading our privacy at the drugstore.

Small potatoes you say?   You must watch for small changes and trends  in an evolving society.   Death can occur by a thousand cuts. (referring to a Chinese torture from 900 AD to 1905)

a. It is becoming common for a customer who arrives at the pharmacy to pick up a new prescription to receive only a one day supply.  Then he has to return the next day for the rest.  What is the harm?  Inconvenience and wasted time is the harm along with exploitation of the consumer.

It is not about your chronic medications which you can call for on Monday and pick up on Wednesday.    But if you visit a doctor who prescribes a new medicine, for example an antibiotic for a urine infection, and you go to pick it up,  you may only receive enough for the first day.   The reason for this is ostensibly because the pharmacy cannot maintain an inventory for all meds, but they certainly could do it for 50 of the most common meds.  Did this inventory issue suddenly happen?   There has to be more to this story, and it is not about putting the patient first.

b. The next issue is very worrisome.   You will find pharmacists interrogating you, at the direction of the insurance or pharmaceutical companies, to find out why you are not taking your medicine the way that they think you should.   For example, if you take a BP drug and you skip doses, or if your doctor has reduced your dose  (eg take half a pill instead of a whole pill,) you will be interrogated as to why you haven’t been refilling your prescription in a timely manner.

The pharmacist will tell you that this is to make sure you are getting proper treatment, but it is just a sly marketing method in a society which allows more and more invasions of our privacy.  It is also intimidation, because  you have to wonder what will happen if you refuse to answer these inappropriate questions.    The pharmacist I spoke to implied that they have no choice but to engage in this unprofessional behavior. She was uncomfortable about it.

But the pharmacist is an accomplice in depriving us of our rights to privacy, and I find that to be deeply disturbing, and I told her that.   We don’t need big Pharma or big government treating us like children and/or asking questions that are none of their business.

Note:  This article is based on my experience at one pharmacy in the area.  I don’t know how prevalent this is.  Consider it a “heads up.”

 

 

Read Full Post »

Good Morning Dr. Paul Goldfinger. Here are today's top stories.Friday, January 22, 2016

Good Morning Dr. Paul Goldfinger. Here are today’s top stories. Friday, January 22, 2016

Fasting blood sugar chart

Fasting blood sugar chart

CBS News reports on a public service ad campaign to encourage people to be checked for prediabetes launched by the American Medical Association, the American Diabetes Association, the Centers for Disease Control and Prevention, and the Ad Council.

HealthDay (1/21,)  reports the message of the campaign is “no one is excused from diabetes.” It also includes “a short online test at DoIHavePrediabetes.org.” that “can also be taken through texts and interactive TV and radio announcements.” The CDC issued a news release announcing the campaign, in which AMA President-Elect Dr. Andrew W. Gurman, MD, said, “As soon as someone discovers they may be at risk of prediabetes, they should talk with their physician about further testing to confirm their diagnosis and discuss the necessary lifestyle changes needed to help prevent type 2 diabetes.”

MedPage Today (1/21, ) reports that Dr. Gurman explained the reason for the campaign: “There are 86 million people in this country who have prediabetes, and 90% don’t know it,” adding, “we need to do something to make people aware of this condition and its risk.” The AMA is also seeking to raise awareness among physicians, “because they may have lots of people coming into their office and saying, ‘I just took the prediabetes test and I think I have it,’” said Gurman.

Blogfinger medical commentary:  By Paul Goldfinger, MD, FACC.

This public service ad campaign is about “prediabetes,” the latest medical issue to strike fear into the hearts of the public. Above, a doctor calls this a “diagnosis.”  Another calls it a “condition.”  But they are all careful not to call prediabetes a “disease.”  It actually is a state of awareness where early detection can result in a prevention program to reduce the risk of  type II diabetes.     In fact, 15-30% of prediabetics eventually get type II diabetes.

Prediabetes  is a name given to a borderline abnormal blood test coupled with the threat that the abnormality will give rise to overt diabetes and to heart disease.Those who are at highest risk of having prediabetes are obese, sedentary, hypertensive males, age 40-60, with a positive family history of diabetes.   The PR buildup will include a massive barrage of ads on TV, internet, doctors offices and elsewhere which will scare people with what amounts to a real concern, but it is not actually a disease, making this PR campaign somewhat unusual.   Maybe it is like the campaign to take BP readings in dental offices or shoe stores.  That way you can identify those with borderline high blood pressure readings who are not quite hypertensive—-ie prehypertensive.

In fact prediabetes has no symptoms, no physical findings, no medicines to take,  and no clear endpoint for therapeutic success except for a normalization of blood sugar levels.  It is really an idea about preventing a disease, diabetes, which can cause death and disability.  Prediabetes, a circumstance that can be found in millions of people,  is certainly a situation worth your attention.  So let’s put it into perspective.

There is type I  diabetes (insulin dependent) and the much more common, but less serious,  type II  (non-insulin dependent or “maturity onset” diabetes.)    The main worry with diabetes is generally not the elevated blood sugar levels (although that could become a problem; ) it is the risk of vascular complications including heart attack, kidney failure, stroke, blindness or amputation. Treating prediabetes is supposed to reduce the risk of clinical diabetes–type II.

The diagnosis of prediabetes is made with blood tests that measure blood sugar levels in a few different ways.  The best test is the A1C  (aka glycohemoglobin test) which averages blood sugar levels over time instead of in a snapshot as occurs with the fasting blood sugar test.  Normal A1C is less than 5.7%; prediabetes is 5.7-6.4% and diabetes is over 6.5%.

If you are said to have “prediabetes,” the usual recommendations include preventive measures which you  would want to do anyhow.  Number one is weight reduction.   Then comes exercise and specific dietary advice.  Control of all cardiac risk factors would be advisable also including BP control, stop smoking, cholesterol treatment, stress reduction, etc.

The Joslin Diabetes Center ( www.joslin.org/info/what_is_pre_diabetes.html  )   at Harvard Med. School says that weight reduction is the most important preventive measure.  They say that calorie reduction is more important than sugar intake. Below is their simple dietary advice if you have prediabetes, but it is good advice for anyone:

—-eating more foods that are broiled and fewer foods that are fried.

—-cutting back on the amount of butter you use in cooking.

—-eating fish and chicken more, and only lean cuts of beef.

—-eating more meatless meals, or re-orienting your meals so that your dinner plate has more vegetables, fruit and starches on it, and less meat.

This is what they say at Joslin, “The solution isn’t “avoid foods with sugar in them.” Rather, you need to lose weight if you are overweight, cut back on portion sizes, and plan for those occasions when you eat a small piece of cake or pie.”

So the latest celebrity disease is upon us, and the treatment is the same as what prevention minded docs have been advocating right along, but another dose of awareness and education could wake up a lot of future diabetics.

 

Read Full Post »

« Newer Posts - Older Posts »